SUPPLEMENTARY MATERIALS AND METHODS

Pre-rRNA processing analysis
Total RNA extraction was performed as previously described (1). Denaturing agarose gels were stained with ethidium bromide to visualize the large mature rRNAs and transferred to nylon membranes for northern blot analysis with suitable probes (as described in 1). The sequences of the oligonucleotide probes used are listed in Table S4 . The 28S/18S ratios were established from electropherograms (Agilent, Bioanalyzer Kit #5067-1511).
Cloning and expression assays
The gene encoding Hvo_1475 (hereafter named HvoMettl5) was amplified by PCR from H. volcanii genomic DNA with oligonucleotides oMG439 and oMG440 (Table S5 ) and the Phusion High-Fidelity DNA Polymerase (Thermo). The PCR products were cloned into the pET28b vector to generate plasmid pMG825 encoding a C-terminally His6-tagged version of the full-length HvoMettl5 protein. Generation of the pET21a-derived pMG564 plasmid encoding untagged HvoTrm112 protein has been described previously (2) . DNA sequences optimized for heterologous expression in E. coli were designed to encode either H. sapiens METTL5 or H. sapiens ZCCHC4, each with a C-terminal His6-tag. These fragments were obtained by de novo synthesis (Integrated DNA Technologies, Belgium) and cloned into pET21a between the NdeI and NotI sites to yield plasmids pMG832 (METTL5) and pMG837 (ZCCHC4). The pFF6 plasmid (kind gift from Dr. V. Heurgué-Hamard, France) was used to express human TRMT112 in E. coli (Table S5; 3) .
Heterologous expression and purification of the HvoMettl5-Trm112 complex
The HvoTrm112 protein was co-expressed with the His6-tagged HvoMettl5 protein in E. coli BL21 (DE3) Gold cells (Agilent technologies) upon co-transformation with pMG825 and pMG564 plasmids (Table S5) . Cultures were carried out in 1 L auto-inducible Terrific Broth (ForMedium AIMTB0260) containing ampicillin (100 µg/mL) and kanamycin (50 µg/mL), first for 3 h at 37°C and then overnight at 18°C. The cells were harvested by centrifugation at 4000 rpm for 30 minutes. The pellet was resuspended in 30 mL lysis buffer L2000 (2 M NaCl, 50 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol, 10 µM ZnCl2, and 10 mM imidazole pH 7.5). This complex was purified as previously described for other HvoTrm112-methyltransferase complexes (2) .
Heterologous expression and purification of the human METTL5-TRMT112 complex
The human TRMT112 and METTL5-His6 proteins were co-expressed in E. coli BL21 (DE3) Gold (Agilent technologies) from plasmids pMG832 and pFF6. Large-scale purification was done from 1 L of culture in auto-inducible Terrific Broth (ForMedium AIMTB0260) containing ampicillin and chloramphenicol. The culture was initially incubated at 37°C for 3 h and then at 18°C overnight. The cells were harvested by centrifugation at 4000 rpm for 30 min and the pellets were resuspended in 30 mL lysis buffer L200 (200 mM NaCl, 50 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol). The cells were lysed by sonication on ice and lysate clearance was performed by centrifugation at 20,000 rpm for 45 min. The supernatant was applied to Ni-NTA resin pre-equilibrated with buffer L200, incubated at 4°C on a rotating wheel for 30 min, followed by three washing steps of 20 mL of L200. The first one was performed with washing buffer L1000 (1 M NaCl, 50 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol), the second one with L200 and the third one with L200 supplemented with 20 mM imidazole pH 7.5. The TRMT112-METTL5 complex was eluted with 10 mL elution buffer (lysis buffer L200 supplemented with 400 mM imidazole pH 7.5). The protein sample was then diluted in buffer L50 (50 mM NaCl, 50 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol) and injected onto a HiTrap Q FF column. The protein complex was eluted with a linear NaCl gradient from 100% of buffer L50 to 100% of buffer L1000. Fractions containing the TRMT112-METTL5 complex were collected and concentrated to 5 mL, injected onto a S75-16/60 size-exclusion chromatography column (GE Healthcare), and eluted with lysis buffer L200.
Effect of coexpressing HvoTrm112 or TRMT112 on the solubility of the associated methyltransferases
For expression assays, E. coli BL21 (DE3) Gold cells transformed with appropriate plasmids (Table S5) were grown in 5 mL TBAI medium supplemented with the relevant antibiotics in 24-deep-well plates, first at 37°C for 3 h and then at 18°C overnight. As ZCCHC4 is predicted to contain a zinc-finger domain, ZnCl2 was added at 100 µM to the culture medium and at 10 µM to the lysis buffer. Cells were harvested by centrifugation at 2000 rpm and 4°C for 15 minutes and then resuspended in 1.2 mL lysis buffer (200 mM NaCl, 20 mM Tris-HCl pH 7.5, 5 mM b-mercaptoethanol) and frozen at -20C°. Thawed cells were sonicated on ice for 1 min. Ten microliters of total extract (TE) was withdrawn for further analysis by SDS-PAGE and western blotting. Cell debris and insoluble proteins were removed by centrifuging for 30 min at 13000 rpm and 4°C. Ten microliters of supernatant (soluble extract or SE) was withdrawn for further analysis by SDS-PAGE and western blotting. The human ZCCHC4+/-TRMT112 and METTL5+/-TRMT112 proteins were further subjected to an affinity chromatography purification on 50 µL Ni-NTA resin pre-equilibrated with lysis buffer. After extensive washing with 2 mL lysis buffer, the bound proteins were incubated with 50 µL of elution buffer (200 mM NaCl, 20 mM Tris-HCl pH 7.5, 5 mM bmercaptoethanol, 400 mM imidazole pH 7) prior to elution. Ten microliters of eluate (E) was withdrawn for further analysis by SDS-PAGE and western blotting. The TE, SE, and E samples were loaded on an 15% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane for immunoblotting. His-tagged proteins were detected with anti-His6 antibodies coupled to peroxidase (SIGMA: #A7058 (1:2000 dilution), while human TRMT112 was detected with rabbit polyclonal antibodies raised against purified TRMT112-METTL5 complex (COVALAB) (1:2500 dilution) as primary antibodies and HRP-conjugated anti-rabbit IgG (1:20000 dilution; SIGMA: #A6154) as secondary antibody. Membranes were incubated for 5 min with 1 mL Lumi-light PLUS substrate solution (ROCHE: #12015196001) and detection was done with a Chemidoc BioRad system.
Size Exclusion Chromatography -Multi-Angle Laser Light Scattering (SEC-MALLS)
The samples (100 µL at 1 mg/mL) were injected at a flow rate of 0.75 mL/min onto a Superdex TM 200 Increase 10/300 GL column (GE-Healthcare) and eluted with buffers L2000 for the HvoMettl5-Trm112 complex and buffer L200 for the METTL5-TRMT112 complex. Elution was monitored with a UV-Visible spectrophotometer, an RID-20A refractive index detector (Shimadzu), and a MiniDawn TREOS detector (Wyatt Technology). The data were collected and processed with the program ASTRA 6.1 (Wyatt Technology) software. Mw was calculated directly from the absolute light scattering measurements, using a dn/dc value of 0.183.
Immunoprecipitation of complexes containing Flag-tagged proteins from human cells
Expression of 2x Flag-PreScission protease cleavage site-His6-METTL5 (Flag-METTL5) or the Flag tag alone was induced in stably transfected HEK293 cells by addition of 1 µg/mL tetracyline for 24 h before harvesting. Cells were lysed by sonication in a buffer containing 50 mM Tris-HCl pH 7.8, 150 mM NaCl, 0.5 mM EDTA, 0.1 % Trition-X-100 supplemented with protease. Cell debris were pelleted by centrifugation and the clear lysate was incubated with anti-Flag (M2) magnetic beads for 2 h at 4 °C. After thorough washing steps, complexes were eluted using 250 µg/mL Flag peptide and proteins were precipitated using trichloroacetic acid (TCA). Proteins were separated by SDS-PAGE and transferred to nitrocellulose membrane for western blotting using antibodies (anti-PNO1 -Proteintech (21059-1-AP); anti-ENP1 (4); anti-Flag -Sigma-Aldrich (F3165)).
miCLIP bioinformatic analyses
Initial processing of raw FASTQ files was performed as in the miCLIP protocol (5). Adapters and low-quality nucleotides were first trimmed from paired reads with flexbar v2.5, then de-multiplexed with the pyBarcodeFilter.py script of the pyCRAC suite. The remainder of the random barcode was moved to the headers of the FASTQ reads with an awk script and PCR duplicates were removed with the pyCRAC pyDuplicateRemover.py script. Reads were aligned to hg38 with bwa v0.7.17, using the option "-n 0.06" as recommended in the CTK package.
To call m 6 A, C-to-T transitions were extracted and the CIMS pipeline of the CTK package was used. Those within the DRACH consensus were then filtered. The sites identified in each replicate were collapsed and metagenes were generated with MetaPlotR (6) . In all cases, the longest GENCODE transcript isoform for each gene was selected. For the genome tracks of the ribosomal RNA gene unit, mapped miCLIP reads containing C-to-T transitions were extracted and plotted with pyGenomeTracks v2.0.
To identify ZCCHC4-or METTL5-dependent m 6 A sites, mapped miCLIP reads containing C-to-T transitions were first converted to transcript coordinates (GRCh38.93) of the longest isoform per gene. Coverage of these within sliding windows (80-nt-width bins with a step size of 40 nt) was counted and normalized to the median count across all windows per gene. To prevent downstream biases due to low read coverage, bins with less than 2% of the maximum were filtered out. Bins were then tested for significantly differential counts between the wild type and each knockout, using the exactTest() function of the edgeR package v3.18.1. miCLIP sequencing data was deposited at the Gene Expression Omnibus database (https://www.ncbi.nlm.nih.gov/geo/) under accession GSE128699.
SUPPLEMENTARY FIGURES
Figure S1: Strategy of METTL5 and ZCCHC4 gene knockout by CRISPR-Cas9 genome editing, diagnostic PCR of the generated cell lines, and m 6 A calibration of our HPLC system A-B. METTL5 (A) and ZCCHC4 (B) gene locus structure, highlighting the exon targeted for deletion by CRISPR-Cas9 editing. The region targeted for deletion, containing the methyltransferase domain, is delineated by red dashed lines. Green, exons; red, N6-adenosine methyltransferase signature (123-VIMNPPF-129 for METTL5; 273-MVTDPPF-279 for ZCCHC4); red arrows, CRISPR guides; cyan arrows, oligonucleotides used for diagnostic PCR. All variants generated were sequenced (see Table S3 ). C. HsTRMT112 solubilizes HsMETTL5 upon co-expression in E. coli. Western blot analysis for the detection of METTL5-His6 (using an anti-His6 antibody; upper panel), and of TRMT112 (using polyclonal antibodies raised against the purified METTL5-TRMT112 complex; lower panel) in total extract (TE) and soluble extract (SE) from E. coli, and in Ni-NTA elution (E) fraction. Note that the antibodies raised against purified METTL5-TRMT112 complex do not react well with human METTL5. The asterisk indicates a non-specific band. As a control, purified human TRMT112 was loaded (right lane).
D.
Chromatogram resulting from SEC-MALLS analyses of human METTL5-TRMT112 complex. A zoom-in centered on the main peak with the refractive index colored in blue (left y-axis) and the distribution of molecular mass calculated from light scattering along this peak colored in red (right y-axis) are shown. SDS-PAGE analysis of the Coomassiestained proteins present in the main peak is shown. E. Co-expressing TRMT112 with ZCCHC4 has no impact on the stability or solubility of ZCCHC4. Western blot analysis for detection of ZCCHC4-His6 (using anti-His6 antibodies, top) and TRMT112 (using antibodies directed against TRMT112-METTL5 human complex, bottom) in total (TE) or soluble (SE) extracts and Ni-NTA elution (E). The asterisk indicates a non-specific band. As a control, purified human TRMT112 was loaded (right lane). A. TRMT112 sequences. Strictly conserved residues appear in white on a black background. Partially conserved amino acids are highlighted with a gray background. Secondary structure elements assigned on the basis of the H. sapiens crystal structure established in this work are indicated above the alignment. Black stars, residues involved in complex formation. Display generated using the ENDsript server (7). B. METTL5 sequences. As in panel B.
C. Mapping of the sequence conservation at the surface of METTL5. Sequence conservation is represented as a gradient of white (no conservation) to red (strict conservation). TRMT112 is shown in light blue. Conservation scores were calculated from an alignment of 29 eukaryotic and archaeal sequences using the ConSurf server (8) . The SAM molecule bound to METTL5 active site is shown as sticks and the methyl group to be transferred is shown as a black sphere. D. Mapping of the electrostatic potential at the surface of human METTL5-TRMT112. Positively charged (5 kBT/e -) and negatively charged (−5 kBT/e -) regions are colored in blue and red, respectively. The electrostatic potential was calculated using the CHARMM-GUI web server (9, 10) . SAM and the transferred methyl group are depicted as in panel C. Figure S5 , panel C for details). Sequence conservation was calculated from the multiple alignments of 35 eukaryal METTL5 or TRMT112 sequences from multi-cellular organisms (the same species were used), using as cut off >45% sequence identity. Archaeal sequences were omitted from the alignment as the central domain of TRMT112 is largely missing in archaea.
The surface conservation analysis on TRMT112 reveals the presence of three conserved regions: 1) the area involved in interaction with the methyltransferase subunit (here: METTL5, but it is the same region which is involved in binding the methyltransferases Mtq2/HEMK2, Bud23/WBSCR22, Trm9/ALKHB8, and Trm11/TRMT11, see 11), 2) a small region located close to the putative active site of METTL5 at the tip of the zinc-binding domain (interestingly, in the context of Mtq2-Trm112 and Trm11-Trm112 complexes from S. cerevisiae, some residues of this area are contributing to enzyme activity by aiding substrate binding, see 12, 13) , and, 3) a region at the solvent-exposed side of TRMT112, opposite the METTL5 active site, which may be involved in interaction with yet to be identified TRMT112 partners.
Figure S7: Superimposition of the crystal structures of human METTL5-TRMT112 and S. cerevisiae Bud23-Trm112 complexes
The cysteine residues involved in coordination of a zinc ion in S. cerevisiae Trm112 protein are shown as sticks (pointing towards the Zn 2+ ); notably, these are absent from human TRMT112, which does not bind zinc (see main text for details). The zinc ion is depicted as a magenta sphere. For the sake of clarity, only the two b-strands involved in formation of the b-zipper are labeled (b3 and b4). The SAM molecules bound to the METTL5 (gold) and Bud23 (dark salmon) methyltransferase domains are shown as sticks, with the methyl group to be transferred onto the RNA substrate (a guanosine for Bud23 and an adenosine for METTL5) shown as black spheres. B. 18S rRNA purified from three independently isolated mettl5 -/-cell lines and from the isogenic control (METTL5 +/+) was digested to single nucleotide and analyzed by HPLC. The m 7 G peak, which eluates ~19 min, is unchanged in the mutants. 
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